Sensitive skin is not "thin skin" — it is a broken barrier plus an over-reactive nervous system. The job of a formula is not to stack actives, but to rebuild the barrier and drive irritation as close to zero as possible.

Why barrier repair is the biggest OEM lane

CeraVe built an empire on three ceramides. Drunk Elephant and Paula's Choice ship barrier-focused lines at premium margins. The category logic holds everywhere: once a sensitive-skin user finds a product that is "non-irritating but actually works," they repurchase at a materially higher rate than the average skincare buyer. For a private label cosmetics manufacturer, that means three things — rigid demand, stable AOV, and a low return rate, but also a high formulation barrier and tight claims. "Gentle" is harder to build than "strong."

The five-ingredient matrix (safe-and-effective ranges)

ActiveRoleRecommended rangeRed line
Ceramide NP/AP/EOPFill the "brick-and-mortar" gaps0.1%–0.5% (blended)Use 3:1:1 with cholesterol + fatty acids
Centella asiatica (TECA)Calm redness, support repair0.5%–2%Screen for aristolochic acid residue
Panthenol (B5)Hydrate, reduce irritation1%–5%Slightly tacky at the top end
α-BisabololAnti-inflammatory, anti-redness0.1%–0.5%Oil-soluble — mind dispersion
EctoinEnvironmental-stress protection0.5%–2%Higher cost, strong story
Evidence note: these are soothing/hydrating pathways. Substantiate with human-use and patch testing — never with "treats dermatitis" or "repairs steroid-damaged skin" language. That is the drug boundary, and cosmetics cannot cross it.

Two formulas you can sample this month

  1. Soothing repair lotion (leave-on): water to 100%, glycerin 3%, panthenol 3%, TECA 1%; squalane 3%, ceramide complex (3:1:1) 0.5%, bisabolol 0.3%; a mild non-ionic emulsifier 2–3%, ectoin 1%; paraben-free preservation, pH 5.5–6.0.
  2. Rescue essence water (high-hydration, low-tack): panthenol 4%, ectoin 1.5%, TECA 0.8%, multi-MW hyaluronic acid 0.1–0.3%, bisabolol 0.2%, glycerin/butylene glycol 4%, water to 100%.

Non-negotiables: fragrance-free, alcohol-free, dye-free; avoid MIT/CMIT and high-dose formaldehyde releasers; keep pH 5.0–6.0; run a 30-subject patch test plus a 28-day human-use study before launch.

Compliance quick view

  • US (FDA MoCRA): cosmetic, no pre-market approval; "hypoallergenic" has no fixed standard — use with caution; no drug claims.
  • EU (1223/2009 + CPNP): CPNP notification + Responsible Person + CPSR; "barrier repair" is a claim you must substantiate, "treatment" is not.

A low MOQ cosmetic manufacturer lets you pilot a 15–30ml trial size before committing to scale. Brief your skincare OEM China or US partner with this framework, keep the claim dossier clean, and let repurchase — not the launch spike — tell you if the barrier story worked.

🔗 Want to sample this barrier-repair formula? → https://www.quickoem.com/en/contact